986
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications

, , , &
Article: 2259996 | Received 06 Jun 2023, Accepted 12 Sep 2023, Published online: 04 Oct 2023

References

  • Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019 Apr;99(2):1–10. doi:10.1152/physrev.00012.2018.
  • Li Y, Wang W, Yang F, et al. The regulatory roles of neutrophils in adaptive immunity. Cell Commun Signal. 2019 Nov;17(1):147. doi:10.1186/s12964-019-0471-y.
  • Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.
  • Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016 Apr;85(4):199–208.
  • Pineault J, Lamarche C, Bell R, et al. Association of neutrophil-to-lymphocyte ratio with inflammation and erythropoietin resistance in chronic dialysis patients. Can J Kidney Health Dis. 2017;4:2054358117735563. doi:10.1177/2054358117735563.
  • Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573–577. doi:10.1586/14779072.2016.1154788.
  • Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020 Nov;18(1):360. doi:10.1186/s12916-020-01817-1.
  • Xie T, Xin Q, Chen R, et al. Clinical value of prognostic nutritional index and neutrophil-to-lymphocyte ratio in prediction of the development of sepsis-induced kidney injury. Dis Markers. 2022;2022:1449758–1449759. doi:10.1155/2022/1449758.
  • Ebert T, Pawelzik SC, Witasp A, et al. Inflammation and premature ageing in chronic kidney disease. Toxins (Basel). 2020 Apr;12(4):227. doi:10.3390/toxins12040227.
  • Song M, Graubard BI, Rabkin CS, et al. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep. 2021 Jan;11(1):464. doi:10.1038/s41598-020-79431-7.
  • Josse JM, Cleghorn MC, Ramji KM, et al. The neutrophil-to-lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis. 2016 Jul;18(7):O236–242. doi:10.1111/codi.13373.
  • Catabay C, Obi Y, Streja E, et al. Lymphocyte cell ratios and mortality among incident hemodialysis patients. Am J Nephrol. 2017;46(5):408–416. doi:10.1159/000484177.
  • Schneider A, Jardine AG, Schneider MP, et al. Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the Aurora study. Am J Nephrol. 2013;37(2):144–151. doi:10.1159/000346710.
  • Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016 Jul;388(10041):276–284. doi:10.1016/S0140-6736(16)30508-6.
  • Chandra A, Raj G, Awasthi NP, et al. Evaluation of the relationship between blood cell parameters and vascular calcification in dialysis-dependent end-stage renal disease patients. Saudi J Kidney Dis Transpl. 2020 Jan-Feb;31(1):136–143.
  • Manyari DE. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med. 1990 Dec;323(24):1706–1707. doi:10.1056/NEJM199012133232413.
  • Li H, Lu X, Xiong R, et al. High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients. Mediators Inflamm. 2017;2017:9327136–9327138. doi:10.1155/2017/9327136.
  • Ureña-Torres P, D’Marco L, Raggi P, et al. Valvular heart disease and calcification in CKD: more common than appreciated. Nephrol Dial Transplant. 2020 Dec;35(12):2046–2053. doi:10.1093/ndt/gfz133.
  • Yun-Dan W, Jiang W. Correlation between hs-CRP, NLR, PLR and cardiac valve calcification in maintenance hemodialysis patients. J Clin Nephrol. 2020;20(2):109–113.
  • Zhu X, Li G, Li S, et al. Neutrophil-to-lymphocyte ratio and red blood cell distribution width-to-platelet ratio predict cardiovascular events in hemodialysis patients. Exp Ther Med. 2020 Aug;20(2):1105–1114. doi:10.3892/etm.2020.8756.
  • Neuen BL, Leather N, Greenwood AM, et al. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38(1):70–76. doi:10.3109/0886022X.2015.1104990.
  • Lano G, Sallée M, Pelletier M, et al. Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis. Nephrol Dial Transplant. 2022;37(12):2528–2537.
  • Zhang Y, Ruan Y, He Q, et al. Clinical significance of neutrophil to lymphocyte ratio in maintenance hemodialysis patients. Chin J Nephrol. 2016;32(9):659–664.
  • Yamada K, Furuya R, Takita T, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008 Jan;87(1):106–113. doi:10.1093/ajcn/87.1.106.
  • Fischer EC, Zócalo Y, Galli C, et al. Arterial stiffness and renal replacement therapy: a controversial topic. Int J Nephrol. 2015;2015:729607–729609. doi:10.1155/2015/729609.
  • Mozos I, Stoian D, Luca CT. Crosstalk between vitamins A, B12, D, K, C, and E status and arterial stiffness. Dis Markers. 2017;2017:8784914–8784971. doi:10.1155/2017/8784971.
  • Vita JA, Keaney JF, Jr., Larson MG, et al. Brachial artery vasodilator function and systemic inflammation in the fFramingham offspring study. Circulation. 2004 Dec;110(23):3604–3609. doi:10.1161/01.CIR.0000148821.97162.5E.
  • Mäki-Petäjä, Kaisa M., Hall, Frances C., Booth, Anthony D., et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006 Sep;114(11):1185–1192. doi:10.1161/CIRCULATIONAHA.105.601641.
  • Yu XY, Li XS, Li Y, et al. Neutrophil-lymphocyte ratio is associated with arterial stiffness in postmenopausal women with osteoporosis. Arch Gerontol Geriatr. 2015 Jul-Aug;61(1):76–80. doi:10.1016/j.archger.2015.03.011.
  • Ayhan H, Kasapkara HA, Aslan AN, et al. Relationship of neutrophil-to-lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus. Can J Diabetes. 2015 Aug;39(4):317–321. doi:10.1016/j.jcjd.2015.01.004.
  • Bitar W, Helve J, Kanerva M, et al. Severe infections in peritoneal dialysis and home hemodialysis patients: an inception cohort study. PLoS One. 2023;18(6):e0286579. doi:10.1371/journal.pone.0286579.
  • Li PK, Chow KM. Infectious complications in dialysis–epidemiology and outcomes. Nat Rev Nephrol. 2011 Dec;8(2):77–88. doi:10.1038/nrneph.2011.194.
  • Laupland KB, Gregson DB, Zygun DA, et al. Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004 Apr;32(4):992–997. doi:10.1097/01.ccm.0000119424.31648.1e.
  • Yang J, Wang H, Hua Q, et al. Diagnostic value of systemic inflammatory response index for catheter-related bloodstream infection in patients undergoing haemodialysis. J Immunol Res. 2022;2022:7453354.
  • Ren W, Pan H, Wang P, et al. Clinical analysis of pulmonary infection in hemodialysis patients. Exp Ther Med. 2014 Jun;7(6):1713–1717. doi:10.3892/etm.2014.1646.
  • Li LL, Yang YQ, Qiu M, et al. The clinical significance of neutrophil-lymphocyte ratio in patients treated with hemodialysis complicated with lung infection. Medicine (Baltimore). 2021 Jul;100(29):e26591. doi:10.1097/MD.0000000000026591.
  • Yan L, Qiu Y, Liu J, et al. Increased thoracic fluid content is associated with higher risk for pneumonia in patients undergoing maintenance hemodialysis. Ren Fail. Dec. 2023;45(1):2207666.
  • Simadibrata DM, Calvin J, Wijaya AD, et al. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: a meta-analysis. Am J Emerg Med. 2021 Apr;42:60–69. doi:10.1016/j.ajem.2021.01.006.
  • Mutinelli-Szymanski P, Hude I, Merle E, et al. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients. Clin Kidney J. 2021 Jan;14(1):124–131. doi:10.1093/ckj/sfaa194.
  • Mayne KJ, Lees JS, Rutherford E, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clin Kidney J. 2023 Mar;16(3):512–520. doi:10.1093/ckj/sfac248.
  • Oguz EG, Yeter HH, Akcay OF, et al. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit and mortality in maintenance hemodialysis patients with COVID-19. Hemodial Int. 2022 Jul;26(3):377–385. doi:10.1111/hdi.13001.
  • Lo CH, Hsu YJ, Hsu SN, et al. Factors associated with length of hospital stay among dialysis patients with nontraumatic acute abdomen: a retrospective observational study. Singapore Med J. 2020 Nov;61(11):605–612. doi:10.11622/smedj.2019106.
  • Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov;42(5):864–881. doi:10.1016/j.ajkd.2003.07.016.
  • Diaz-Martinez J, Campa A, Delgado-Enciso I, et al. The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients. Int Urol Nephrol. 2019 Jul;51(7):1239–1247. doi:10.1007/s11255-019-02166-6.
  • Yilmaz H, Bozkurt A, Cakmak M, et al. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil-lymphocyte ratio (NLR) in chronic hemodialysis patients. Ren Fail. 2014 Oct;36(9):1390–1394. doi:10.3109/0886022X.2014.945183.
  • Çildağ MB, Çildağ S, Köseoğlu ÖF. The relationship between neutrophil-lymphocyte ratio and primary patency of percutaneous transluminal angioplasty in hemodialysis arteriovenous fistula stenosis when using conventional and drug-eluting balloons. Cardiovasc Intervent Radiol. 2016 Dec;39(12):1702–1707. doi:10.1007/s00270-016-1442-y.
  • Bashar K, Zafar A, Ahmed K, et al. Can a neutrophil-lymphocyte ratio derived from preoperative blood tests predict arteriovenous fistula maturation? Ann Vasc surg. 2016 Aug;35:60–67.
  • Kara AV, Soylu YE. The relationship between vitamin D and inflammatory markers in maintenance hemodialysis patients. Int Urol Nephrol. 2019 Sep;51(9):1659–1665. doi:10.1007/s11255-019-02250-x.
  • Zhang J, Lu X, Wang S, et al. Neutrophil-to-lymphocyte ratio and erythropoietin resistance among maintenance hemodialysis patients. Blood Purif. 2022;51(8):708–713. doi:10.1159/000519644.
  • Valga F, Monzón T, Henriquez F, et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional study. Nefrologia (Engl Ed). 2020 May-Jun;40(3):320–327. doi:10.1016/j.nefroe.2020.06.010.
  • Wang J, Huang L, Xu M, et al. Study on the clinical implications of NLR and PLR for diagnosing frailty in maintenance hemodialysis patients and their correlations with patient prognosis. J Healthc Eng. 2022;2022:1267200. doi:10.1155/2022/1267200.
  • Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010 Aug;363(7):609–619. doi:10.1056/NEJMoa1000552.
  • Lee TW, Bae W, Choi J, et al. The neutrophil-to-lymphocyte ratio may indicate when to start hemodialysis. Ren Fail. Dec. 2022;44(1):1401–1408.
  • Ng CH, Ong ZH, Sran HK, et al. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis. Int Urol Nephrol. 2021 Jul;53(7):1363–1371. doi:10.1007/s11255-020-02683-9.
  • Mehrotra R, Devuyst O, Davies SJ, et al. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016 Nov;27(11):3238–3252. doi:10.1681/ASN.2016010112.
  • Zeng Y, Chen Z, Chen Q, et al. Neutrophil to lymphocyte ratio predicts adverse cardiovascular outcome in peritoneal dialysis patients younger than 60 years old. Mediators Inflamm. 2020;2020:4634736.
  • Zhang L, Nie Y, Guo M, et al. Neutrophil to lymphocyte ratio as a predictor of long-term outcome in peritoneal dialysis patients: a 5-year cohort study. Blood Purif. 2021;50(6):772–778. doi:10.1159/000510552.
  • Lau LFS, Ng JK, Fung WW, et al. Relationship between serial serum neutrophil-lymphocyte ratio, cardiovascular mortality, and all-cause mortality in Chinese peritoneal dialysis patients. Kidney Blood Press Res. 2023 Apr;48(1):414–423.
  • Angkananard T, Janma J, Wannasiri T, et al. Associations of left ventricular systolic dysfunction with the factors among Thai patients on peritoneal dialysis: a cross-sectional study. BMC Nephrol. 2019 Jul;20(1):257. doi:10.1186/s12882-019-1418-7.
  • Fornazarič D, Antonič M, Knap B. Volume status and arterial stiffness evaluation in peritoneal dialysis patients. Clin Nephrol. 2021;96(1):74–79. doi:10.5414/CNP96S13.
  • Cai K, Luo Q, Zhu B, et al. Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis. BMC Nephrol. 2016 Nov;17(1):191. doi:10.1186/s12882-016-0394-4.
  • Ato D. Brachial-ankle pulse wave velocity, cardio-ankle vascular index, and prognosis. Vasc Health Risk Manag. 2018;14:321–348. doi:10.2147/VHRM.S179366.
  • Lu X, Wang S, Zhang G, et al. High neutrophil-to-lymphocyte ratio is a significant predictor of cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis. Kidney Blood Press Res. 2018;43(2):490–499. doi:10.1159/000488696.
  • An X, Mao HP, Wei X, et al. Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients. Int Urol Nephrol. 2012 Oct;44(5):1521–1528. doi:10.1007/s11255-012-0130-3.
  • Guo G, Zeng Y, Chen Q, et al. High neutrophil/lymphocyte ratio as an independent risk factor for the first occurrence of stroke in peritoneal dialysis patients. Iran J Kidney Dis. 2020 Jul;14(4):282–289.
  • Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014 Aug;64(2):278–289. doi:10.1053/j.ajkd.2014.02.025.
  • He P, He LJ, Huang C, et al. Neutrophil-to-lymphocyte ratio and treatment failure in peritoneal dialysis-associated peritonitis. Front Med (Lausanne). 2021;8:699502. doi:10.3389/fmed.2021.699502.
  • Zhou D, Yang H, Zeng L, et al. Calculated inflammatory markers derived from complete blood count results, along with routine laboratory and clinical data, predict treatment failure of acute peritonitis in chronic peritoneal dialysis patients. Ren Fail. 2023 Dec;45(1):2179856.
  • Fung WW, Chow KM, Ng JK, et al. The clinical utility of the neutrophil-to-lymphocyte ratio as a discriminatory test among bacterial mycobacterium tuberculosis, and nontuberculous mycobacterium peritoneal dialysis-related peritonitis. Kidney. 2022 Jun;3(6):1031–1038.
  • Bilen Y, Cankaya E, Bilen N, et al. Peritonitis incidence was correlated with duration of peritoneal dialysis rather than leptin or neutrophil to lymphocyte (n/l) ratio in peritoneal dialysis patients. Eurasian J Med. 2014 Oct;46(3):145–150. doi:10.5152/eajm.2014.45.
  • Zhang Y, Lai X, Chen Q, et al. The relationship between neutrophil-to-lymphocyte ratio and the first occurrence of pneumonia in peritoneal dialysis patients. Clin Exp Nephrol. 2020 Sep;24(9):770–778. doi:10.1007/s10157-020-01894-9.
  • Xu LC, Zhou FF, Li M, et al. Predictive value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on patient survival with peritoneal dialysis. Clin Lab. 2021 Sep 1;67(9). doi:10.7754/Clin.Lab.2021.210124.
  • Liu X, Huang R, Wu H, et al. Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients. Sci Rep. 2016 Aug;6(1):32359. doi:10.1038/srep32359.
  • Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton). 2007 Aug;12(4):321–330. doi:10.1111/j.1440-1797.2007.00810.x.
  • Gong LF, Lu JK, Xu M, et al. Higher serum cholesterol and neutrophil-to-lymphocyte ratio at dialysis initiation are risk factors for technique failure among patients undergoing peritoneal dialysis. Int J Clin Exp Med. 2019;12(9):11825–11830.
  • de Rooij ENM, Meuleman Y, de Fijter JW, et al. Symptom burden before and after dialysis initiation in older patients. Clin J Am Soc Nephrol. 2022 Dec;17(12):1719–1729. doi:10.2215/CJN.09190822.
  • Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014 Jun;106(6):dju124.
  • de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. doi:10.1186/cc9309.
  • Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012 Feb;32(2):297–302. doi:10.1111/j.1478-3231.2011.02639.x.
  • Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372–376. doi:10.3109/14397595.2015.1091136.
  • Spark JI, Sarveswaran J, Blest N, et al. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg. 2010 Sep;52(3):632–636. doi:10.1016/j.jvs.2010.03.067.
  • Sadik CD, Kim ND, Luster AD. Neutrophils cascading their way to inflammation. Trends Immunol. 2011 Oct;32(10):452–460. doi:10.1016/j.it.2011.06.008.
  • Beberashvili I, Omar MA, Nizri E, et al. Combined use of CRP with neutrophil-to-lymphocyte ratio in differentiating between infectious and noninfectious inflammation in hemodialysis patients. Sci Rep. 2023 Apr;13(1):5463. doi:10.1038/s41598-023-32270-8.
  • Okyay GU, Inal S, Oneç K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35(1):29–36. doi:10.3109/0886022X.2012.734429.